New Delhi: Aditya Birla Nuvo Ltd (ABNL) on Friday reported 24.16 per cent increase in net profit at Rs 331.33 crore for the first quarter ended June 30, 2013, driven by strong performance from all its business verticals. The company had reported net profit of Rs 266.84 crore in the same quarter a year ago. Aditya Birla Nuvo’s net sales during the quarter under review were at Rs 5,680.14 crore, an increase of 8.11 per cent as against Rs 5,253.58 in the corresponding period last year, the company said in a BSE filing. “Amidst the challenging marco-economic scenario, ABNL has posted strong earnings growth. The company is competitively well positioned in most of its business,” it said in a statement. During the quarter, revenue from branded apparels and accessories were at Rs 982.06 crore, an increase of 87.41 per cent while revenue from textiles grew marginally by 2.84 per cent at Rs 312.84 crore.
TVS Motor Q1 net rises marginally
new delhi: TVS Motor Company has posted a marginal increase of 1.50 per cent in its net profit to Rs 51.87 crore for the first quarter ended June 30, 2013, due to sluggish sales. The company had posted a net profit of Rs 51.1 crore during the same period previous fiscal. Net sales of the company, however, declined by 4.42 per cent to Rs 1,740.19 crore for the quarter under review, as compared to Rs 1,820.73 crore in the same period a year ago, the company said in a filing to the BSE. The total two wheeler sales for the quarter ended June 2013 stood at 4.60 lakh units, it added.
Aurobindo comes out of the red
new delhi: Aurobindo Pharma on Friday posted consolidated net profit of Rs 18.60 crore for the first quarter ended June 30, 2013. The Hyderabad-based firm had posted net loss of Rs 128.91 crore during the April-June quarter of 2012-13 fiscal. Net Q1 sales of the company rose to Rs 1,699.60 crore, as against Rs 1,197.44 crore during the same period of the previous fiscal, Aurobindo Pharma said in a statement. “Our focus on costs and the qualitative aspect of sales across key markets have reflected positively on our revenues and operating margins on a year-on-year basis,” Aurobindo Pharma Ltd managing director N Govindarajan said.
Cipla Q1 net up 10% at R485 crore
new delhi: Drug major Cipla on Friday posted 10.28 per cent rise in consolidated net profit